Jonathan Hartzel
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Pneumonia and Respiratory Infections, Virology and Viral Diseases, Respiratory viral infections research, SARS-CoV-2 and COVID-19 Research, Vaccine Coverage and Hesitancy
Most-Cited Works
- → Ten year follow-up of healthy children who received one or two injections of varicella vaccine(2004)383 cited
- → Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic Surgery(2013)361 cited
- → Multinomial logit random effects models(2001)182 cited
- → Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials(2020)114 cited
- → Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants(2018)107 cited
- → Continuous Passive Motion after Repair of the Rotator Cuff. A Prospective Outcome Study*(1998)103 cited
- → Strategies for comparing treatments on a binary response with multi-centre data(2000)102 cited
- → Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: An analysis of possible contributing host factors(2014)92 cited
- → The Impact of 2D Versus 3D Quantitation of Tumor Bulk Determination on Current Methods of Assessing Response to Treatment(1996)76 cited
- → Informed consent forms for clinical and research imaging procedures: how much do patients understand?(1995)72 cited